Yoshiki Kusunoki

1.2k citations

57 papers · 922 indexed · h-index 19

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Management and Research 21
- Diabetes Treatment and Management 20
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 7
Gastroenterology top 10%
Nephrology top 10%
Physiology
- Diet and metabolism studies 5
Surgery
- Pancreatic function and diabetes 10
Molecular Biology
- Metabolism, Diabetes, and Cancer 9
Experimental and Cognitive Psychology
- Sleep and related disorders 4
Oncology
- Drug Transport and Resistance Mechanisms 4

Co-authors: Risako Kon Kiyoshi Sugiyama Nobutomo Ikarashi Tomoyuki Katsuno Mitsuyoshi Namba Wataru Ochiai Yoshiaki Machida Jun‐ichiro Miyagawa
Cited by: Endocrinology, Diabetes and Metabolism Pharmacology Gastroenterology
Partner nations: Japan France Australia

In The Last Decade

Yoshiki Kusunoki

56 papers receiving 904 citations

Peers

Countries citing papers authored by Yoshiki Kusunoki

Since Specialization

Citations

This map shows the geographic impact of Yoshiki Kusunoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiki Kusunoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiki Kusunoki more than expected).

Fields of papers citing papers by Yoshiki Kusunoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiki Kusunoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiki Kusunoki. The network helps show where Yoshiki Kusunoki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yoshiki Kusunoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoshiki Kusunoki Line = papers co-authored together Yoshiki Kusunoki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study Yuta Nakamura,Ichiro Horie,Tadahiro Kitamura,Yoshiki Kusunoki,Kenro Nishida,Akane Yamamoto,Yushi Hirota,Tomoyasu Fukui,Yasutaka Maeda,Masae Minami,Takanori Matsui,Atsushi Kawakami,Norio Abiru	2024	1
2	Excessive daytime napping independently associated with decreased insulin sensitivity in cross-sectional study – Hyogo Sleep Cardio-Autonomic Atherosclerosis cohort study Miki Kakutani‐Hatayama,M Kadoya,Akiko Morimoto,Akio Miyoshi,Kae Kosaka‐Hamamoto,Akinori Kanzaki,Kosuke Konishi,Yoshiki Kusunoki,Takuhito Syoji,Hidenori Koyama	2023	4
3	Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study Ayako Takagi,Yoshiki Kusunoki,Mana Ohigashi,Keiko Osugi,Chikako Inoue,Maki Inoue,Taku Tsunoda,M Kadoya,Kosuke Konishi,Tomoyuki Katsuno,Hidenori Koyama,(unknown)	2023	2
4	Xanthine oxidoreductase activity is correlated with hepatic steatosis Chisako Yagi,Yoshiki Kusunoki,Taku Tsunoda,Takayo Murase,Takashi Nakamura,Keiko Osugi,Mana Ohigashi,Akiko Morimoto,Akio Miyoshi,Miki Kakutani‐Hatayama,Kae Kosaka‐Hamamoto,M Kadoya,Kosuke Konishi,Takuhito Shoji,Hidenori Koyama	2022	11
5	Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID) Yuta Nakamura,Ichiro Horie,Shigeki Tashiro,Masaki Kobayashi,Tadahiro Kitamura,Yoshiki Kusunoki,Kenro Nishida,Akane Yamamoto,Yushi Hirota,Tomoyasu Fukui,Dan Sekiguchi,Yasutaka Maeda,Masae Minami,Takanori Matsui,Atsushi Kawakami,Norio Abiru	2021	1
6	Sleep quality, autonomic dysfunction and renal function in diabetic patients with pre-CKD phase M Kadoya,Akiko Morimoto,Akio Miyoshi,Miki Kakutani‐Hatayama,Kae Kosaka‐Hamamoto,Kosuke Konishi,Yoshiki Kusunoki,Takuhito Shoji,Hidenori Koyama	2021	5
7	Associations of sleep quality, sleep apnea and autonomic function with insulin secretion and sensitivity: HSCAA study Miki Kakutani‐Hatayama,M Kadoya,Akiko Morimoto,Akio Miyoshi,Kae Kosaka‐Hamamoto,Yoshiki Kusunoki,Takuhito Shoji,Hidenori Koyama	2020	14
8	Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora Nobutomo Ikarashi,Sosuke Ogawa,Ryuta Hirobe,Risako Kon,Yoshiki Kusunoki,Marin Yamashita,Nanaho Mizukami,Miho Kaneko,Nobuyuki Wakui,Yoshiaki Machida,Kiyoshi Sugiyama	2017	25
9	Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans Kahori Washio,Yoshiki Kusunoki,Takayo Murase,Takashi Nakamura,Keiko Osugi,Mana Ohigashi,Tadahiko Sukenaga,Fumihiro Ochi,Toshihiro Matsuo,Tomoyuki Katsuno,Yuji Moriwaki,Tetsuya Yamamoto,Mitsuyoshi Namba,Hidenori Koyama	2017	53
10	High-dose green tea polyphenol intake decreases CYP3A expression in a liver-specific manner with increases in blood substrate drug concentrations Nobutomo Ikarashi,Sosuke Ogawa,Ryuta Hirobe,Yoshiki Kusunoki,Risako Kon,Wataru Ochiai,Kiyoshi Sugiyama	2016	11
11	Mice with neuropathic pain exhibit morphine tolerance due to a decrease in the morphine concentration in the brain Wataru Ochiai,Mitsumasa Kaneta,Marina Nagae,Ami Yuzuhara,Xin Li,Haruka Suzuki,Mika Hanagata,Satoshi Kitaoka,Wataru Suto,Yoshiki Kusunoki,Risako Kon,Kazuhiko Miyashita,Daiki Masukawa,Nobutomo Ikarashi,Minoru Narita,Tsutomu Suzuki,Kiyoshi Sugiyama	2016	19
12	Very Short-Term Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on the Secretion of Insulin, Glucagon, and Incretin Hormones in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Meal Tolerance Test Data Kazuki Murai,Tomoyuki Katsuno,Jun‐ichiro Miyagawa,Toshihiro Matsuo,Fumihiro Ochi,Masaru Tokuda,Yoshiki Kusunoki,Masayuki Miuchi,Mitsuyoshi Namba	2014	14
13	Menthol reduces the anticoagulant effect of warfarin by inducing cytochrome P450 2C expression Motohiro Hoshino,Nobutomo Ikarashi,Makoto Tsukui,Asako Kurokawa,Rina Naito,Midori Suzuki,Kohsuke Yokobori,Takumi Ochiai,Makoto Ishii,Yoshiki Kusunoki,Risako Kon,Wataru Ochiai,Nobuyuki Wakui,Yoshiaki Machida,Kiyoshi Sugiyama	2014	9
14	Medium-Term Effects of Insulin Degludec on Patients with Type 1 Diabetes Mellitus Rie Nakae,Yoshiki Kusunoki,Tomoyuki Katsuno,Masaru Tokuda,Takafumi Akagami,Kazuki Murai,Tomoya Hamaguchi,Jun‐ichiro Miyagawa,Mitsuyoshi Namba	2014	7
15	Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis Yoshiki Kusunoki,Nobutomo Ikarashi,Yoshitaka Hayakawa,Makoto Ishii,Risako Kon,Wataru Ochiai,Yoshiaki Machida,Kiyoshi Sugiyama	2014	44
16	Effects of the naturally‐occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non‐obese subjects Aya Maeda,Jun‐ichiro Miyagawa,Masayuki Miuchi,Etsuko Nagai,Kosuke Konishi,Toshihiro Matsuo,Masaru Tokuda,Yoshiki Kusunoki,Humihiro Ochi,Kazuki Murai,Tomoyuki Katsuno,Tomoya Hamaguchi,Yutaka Harano,Mitsuyoshi Namba	2013	38
17	Total gastrectomy may result in reduced drug effectiveness due to an increase in the expression of the drug-metabolizing enzyme Cytochrome P450, in the liver Makoto Ishii,Takahiro Toda,Nobutomo Ikarashi,Yoshiki Kusunoki,Risako Kon,Wataru Ochiai,Yoshiaki Machida,Kiyoshi Sugiyama	2013	7
18	New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy Mitsuyoshi Namba,Tomoyuki Katsuno,Yoshiki Kusunoki,Toshihiro Matsuo,Masayuki Miuchi,Jun‐ichiro Miyagawa	2012	18
19	Consumption of a high-fat diet during pregnancy decreases the activity of cytochrome P450 3a in the livers of offspring Masataka Tajima,Nobutomo Ikarashi,Yukari Imahori,Takehiro Okaniwa,Kanako Saruta,Makoto Ishii,Yoshiki Kusunoki,Risako Kon,Takahiro Toda,Wataru Ochiai,Harumi Yamada,Kiyoshi Sugiyama	2012	10
20	Incretin responses to oral glucose load in Japanese non-obese healthy subjects Etsuko Nagai,Tomoyuki Katsuno,Jun‐ichiro Miyagawa,Kosuke Konishi,Masayuki Miuchi,Fumihiro Ochi,Yoshiki Kusunoki,Masaru Tokuda,Kazuki Murai,Tomoya Hamaguchi,Mitsuyoshi Namba	2011	6

About Yoshiki Kusunoki

Yoshiki Kusunoki is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Nephrology, having authored 57 papers that have together received 922 indexed citations. Recurring topics across this work include Diabetes Management and Research (21 papers), Diabetes Treatment and Management (20 papers), Pancreatic function and diabetes (10 papers), Metabolism, Diabetes, and Cancer (9 papers), Pharmacogenetics and Drug Metabolism (7 papers), Diet and metabolism studies (5 papers), Sleep and related disorders (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (335 citations), Pharmacology (124 citations) and Gastroenterology (64 citations). Yoshiki Kusunoki has collaborated with scholars based in Japan, France and Australia. Frequent co-authors include Risako Kon, Kiyoshi Sugiyama, Nobutomo Ikarashi, Tomoyuki Katsuno, Mitsuyoshi Namba, Wataru Ochiai, Yoshiaki Machida, Jun‐ichiro Miyagawa, Toshihiro Matsuo and Masayuki Miuchi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact